Aoxiang Pharmaceutical (603229.SH) released results for the first three quarters, with net profit of 71.9313 million yuan to mother, a year-on-year decrease of 65.26%

Zhitongcaijing · 4d ago

According to Zhitong Finance App News, Aoxiang Pharmaceutical (603229.SH) disclosed its 2026 third quarter report. The company achieved revenue of 610 million yuan in the first three quarters, a year-on-year decrease of 5.53%; net profit to mother of 71.9313 million yuan, a year-on-year decrease of 65.26%; deducted non-net profit of 56,1982 million yuan, a year-on-year decrease of 69.33%; basic earnings per share were 0.09 yuan.